Endometrial intraepithelial neoplasia

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 4, 2014, Pages 484-491

  Owings, Richard A ^a   Quick, Charles M ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAX2 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN; TRANSCRIPTION FACTOR PAX2;

ARTICLE; CARCINOMA IN SITU; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; FEMALE; GENETICS; HUMAN; METAPLASIA; MUTATION; PATHOLOGY;

CARCINOMA IN SITU; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; METAPLASIA; MUTATION; PAX2 TRANSCRIPTION FACTOR; PTEN PHOSPHOHYDROLASE;

EID: 84898428706     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0709-RA     Document Type: Article

References (32)

1. Baak JPA, Mutter GL. EIN and WHO94. J Clin Pathol. 2005;58(1):1-6.
2. Hecht JL, Ince TA, Baak JPA, Baker HE, Ogden MW, Mutter GL. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis. Mod Pathol. 2008;18(3):324-330.
3. Orbo A, Baak JPA, Kleivan I, et al. Computerized morphometrical analysis in endometrial hyperplasia for the prediction of cancer development: a long-term retrospective study from northern Norway. J Clin Pathol. 2000;53(9):697-703.
4. Usubutun A, Mutter GL, Saglam A, et al. Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists. Mod Pathol. 2012;25(6):877-884.
5. Baak JP, Mutter GL, Robboy S, et al. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer. 2005;103(11): 2304-2312.
6. Allison KH, Reed SD, Voigt LF, Jordan CD, Newton KM, Garcia RL. Diagnosing endometrial hyperplasia: why is it so difficult to agree Am J Surg Pathol. 2008; 32(5):691-698.
7. Kendall BS, Ronnett BM, Isacson C, Cho KR, Hedrick L, Diener-West MKR. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol. 1998;22(8):1012-1019.
8. Salman MC, Usubutun A, Boynukalin K, Yuce K. Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia. J Gynecol Oncol. 2010;21(2): 97-101.
9. Zaino RJ, Kauderer J, Trimble CL, et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106(4):804-811.
10. Boruban MC, Altundag K, Kilic GS, Blankstein J. From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures. Eur J Cancer Prev. 2008;17(2):133-138.
11. Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol. 2006;24(29):4783-4791.
12. Quick, CM, Laury, AR, Monte NM, Mutter, GL. Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia. American J Clin Pathol. 2012;138:679-684.
13. Mutter GL, Zaino RJ, Baak JPA, Bentley RC, Robboy SJ. Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol. 2007;26(2):103-114.
14. Kane SE, Hecht JL. Endometrial intraepithelial neoplasia terminology in practice: 4-year experience at a single institution. Int J Gynecol Pathol. 2012; 31(2):160-165.
15. Baak JPA, Van Diermen B, Steinbakk A, et al. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression. Hum Pathol. 2005;36(5):555-561.
16. Mutter GL, Lin M, Fitzgerald JT, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst. 2000;92(11):924-931.
17. Mutter GL; Endometrial Collaborative Group. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos Gynecol Oncol. 2000;76(3):287- 290.
18. Allison KH, Upson K, Reed S, et al. PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia. Int J Gynecol Pathol. 2012; 31(2):151-159.
19. Monte NM, Webster KA, Neuberg D, Dressler GR, Mutter GL. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. Cancer Res. 2010;70(15):6225-6232.
20. Mutter GL, Kauderer J, Baak JPA, Alberts DA. Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma: a gynecologic oncology group study. Hum Pathol. 2008;39(6):866-874.
21. Lacey JV Jr, Mutter GL, Nucci MR, et al. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer. 2008;113(8):2073-2081.
22. Trimbel CL, Kaudener J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study. Cancer. 2006;106(4):812-819.
23. Glede KC, Yen T, Chibbar R, Plerson R. Significance of concurrent endometrial cancer in women with a preoperative diagnosis of atypical endometrial hyperplasia. J Obstet Gynaecol Can. 2008;30(10):896-901.
24. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia: a long-term study of ''untreated'' hyperplasia in 170 patients. Cancer. 1985;56(2):403-412.
25. Huang EC, Mutter GL, Crum CP, Nucci MR. Clinical outcome in diagnostically ambiguous foci of ''gland crowding'' in the endometrium. Mod Pathol. 2010 23(11):1486-1491.
26. Marotti JD, Glatz K, Parkash V, Hecht JL. International internet-based assessment of observer variability for diagnostically challenging endometrial biopsies. Arch Pathol Lab Med. 2011;135(4):464-470.
27. Carlson JW, Mutter GL. Endometrial intraepithelial neoplasia is associated with polyps and frequently has metaplastic change. Histopathology. 2008;53(3): 325-332.
28. Lin MC, Lomo L, Baak JP, et al. Squamous morules are functionally inert elements of premalignant endometrial neoplasia. Mod Pathol. 2008;22(2):167- 174.
29. Chiarelli S, Buritica C, Litta P, Ciani S, Guarch R, Nogales FF. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia. Clin Cancer Res. 2006;12(14, pt 1):4251-4256.
30. Kaku T, Tsukamoto N, Tsuruchi N, Sugihara K, Kamura T, Nakano H. Endometrial metaplasia associated with endometrial carcinoma. Obstet Gynecol. 1992;80(5):812-816.
31. Moritani S, Kushima R, Ichihara S, et al. Eosinophilic cell change of the endometrium: a possible relationship to mucinous differentiation. Mod Pathol. 2005;18(9):1243-1248.
32. Gultekin, M, Diribas K, Dursan P, Ayhan A. Current management of endometrial hyperplasia and endometrial intraepithelial neoplasia (EIN). Eur J Gynaecol Oncol. 2009;30(4):396-401.